« Back
Second Quarter Results for Fiscal 2015
Apr 29, 2015
Key highlights:
-
Signed definitive agreement on
April 29, 2015 , to acquire a substantial majority ofComverse's business support systems (BSS) business unit assets for approximately$272 million in cash, subject to customary closing conditions. The Boards of Directors ofComverse andAmdocs have approved the transaction which, subject to the satisfaction of the conditions to closing, is expected to be completed before the end ofSeptember 2015 -
Second fiscal quarter revenue of
$903 million , within the$900-$930 million guidance range. Excluding foreign currency movements, revenue was in line with the midpoint of our expectations. Foreign currency movements negatively affected revenue by approximately$16 million relative to the first quarter of fiscal 2015 -
Second fiscal quarter non-GAAP operating income of
$153 million ; non-GAAP operating margin of 17.0%; GAAP operating income of$138 million -
Second fiscal quarter diluted non-GAAP EPS of
$0.82 , within the$0.78-$0.84 guidance range, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in fair value of certain acquisition-related liabilities and equity-based compensation expense, net of related tax effects -
Diluted GAAP EPS of
$0.74 for the second fiscal quarter, above the$0.64-$0.72 guidance range -
Free cash flow of
$115 million for the second fiscal quarter -
Repurchased
$111 million of ordinary shares during the second fiscal quarter -
Twelve-month backlog of
$3.0 billion at the end of the second fiscal quarter, down$30 million from the end of the first quarter of fiscal 2015. Excluding foreign currency movements, twelve-month backlog was up$30 million from the end of the first quarter of fiscal 2015 -
The Board of Directors approved a
$0.17 per share quarterly cash dividend to be paid onJuly 17, 2015 -
Third quarter fiscal 2015 guidance: Expected revenue of approximately
$885-$925 million . Expected diluted non-GAAP EPS of approximately$0.79-$0.85 , excluding amortization of purchased intangible assets and other acquisition-related costs and approximately$0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Expected diluted GAAP EPS of approximately$0.65-$0.73 . Third quarter fiscal 2015 guidance does not incorporate any contribution from the acquisition of the Comverse BSS assets -
Full year fiscal 2015 revenue guidance: Reiterates fiscal 2015 revenue growth within the range of 2.5% to 5.5% year-over-year on a constant currency basis relative to the guidance provided on
November 4, 2014 . Expects fiscal 2015 reported revenue growth of 0.3% to 3.3% year-over-year reflecting a negative impact from foreign currency movements of over 2% relative to the guidance provided onNovember 4, 2014 . Full year fiscal 2015 guidance does not incorporate any contribution from the acquisition of the Comverse BSS assets -
The impact of the acquisition of the Comverse BSS assets on
Amdocs' diluted non-GAAP earnings per share (excluding amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expense, net of related tax effects) is expected to be neutral in the first year after closing, and accretive thereafter. The impact on diluted GAAP EPS will not be known until afterAmdocs completes the purchase price allocation.Amdocs expects to incur acquisition-related expenses related to operating adjustments, restructuring charges and other acquisition-related costs
"We are pleased with our second fiscal quarter results, which included revenue in line with the mid-point of our expectations after adjusting for the negative impact of foreign currencies. We remained focused on delivering value to our customers, including in
Gelman continued, "Our Rest-of-World markets delivered record revenue in the second quarter as we made progress on a number of highly complex transformation projects.
Gelman said, "The strategic use of M&A remains an important vehicle for executing on our long-term objectives. Along these lines, today we signed a definitive agreement to acquire a substantial majority of the business support system assets of
Gelman concluded, "We returned more than 100% of free cash flow to shareholders in the second fiscal quarter, and with the stability of our business model and consistent operating execution, we remain committed to our balanced capital allocation framework over the long-term. Taking all factors into consideration, we are on-track to deliver diluted non-GAAP earnings per share growth of 4.5%-7.5% for the full fiscal year 2015, and, with our dividend yield, maximize the total return we expect to provide to shareholders."
Financial Discussion of Second Fiscal Quarter Results
Free cash flow was
Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was
Financial Outlook
Diluted earnings per share on a non-GAAP basis for the third fiscal quarter are expected to be
Quarterly Cash Dividend Program
On
Conference Call Details
Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expense, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:
- amortization of purchased intangible assets and other acquisition-related costs;
- changes in fair value of certain acquisition-related liabilities
- equity-based compensation expense; and
- tax effects related to the above.
These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles.
For its internal budgeting process and in monitoring the results of the business,
About
For more than 30 years,
For more information, visit
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about
AMDOCS LIMITED | ||||
Consolidated Statements of Income | ||||
(in thousands, except per share data) | ||||
Three months ended | Six months ended | |||
March 31, | March 31, | |||
2015 | 2014 | 2015 | 2014 | |
Revenue | $902,578 | $896,854 | $1,808,865 | $1,760,899 |
Operating expenses: | ||||
Cost of revenue | 580,571 | 583,284 | 1,154,017 | 1,140,687 |
Research and development | 62,805 | 63,104 | 126,446 | 125,429 |
Selling, general and administrative | 107,186 | 110,438 | 220,766 | 222,397 |
Amortization of purchased intangible assets and other | 14,016 | 16,180 | 28,115 | 27,848 |
764,578 | 773,006 | 1,529,344 | 1,516,361 | |
Operating income | 138,000 | 123,848 | 279,521 | 244,538 |
Interest and other expense, net | 1,669 | 1,908 | 125 | 3,312 |
Income before income taxes | 136,331 | 121,940 | 279,396 | 241,226 |
Income taxes | 20,070 | 11,583 | 32,145 | 29,434 |
Net income | $116,261 | $110,357 | $247,251 | $211,792 |
Basic earnings per share | $0.75 | $0.69 | $1.59 | $1.33 |
Diluted earnings per share | $0.74 | $0.68 | $1.57 | $1.31 |
Basic weighted average number of shares outstanding | 155,106 | 159,812 | 155,506 | 159,734 |
Diluted weighted average number of shares outstanding | 157,357 | 162,251 | 157,738 | 162,048 |
Cash dividends declared per share | $0.170 | $0.155 | $0.325 | $0.285 |
AMDOCS LIMITED | ||||
Selected Financial Metrics | ||||
(in thousands, except per share data) | ||||
Three months ended | Six months ended | |||
March 31, | March 31, | |||
2015 | 2014 | 2015 | 2014 | |
Revenue | $902,578 | $896,854 | $1,808,865 | $1,760,899 |
Non-GAAP operating income | 153,491 | 150,563 | 306,453 | 295,886 |
Non-GAAP net income | 128,647 | 131,850 | 268,132 | 254,414 |
Non-GAAP diluted earnings per share | $0.82 | $0.81 | $1.70 | $1.57 |
Diluted weighted average number of shares outstanding | 157,357 | 162,251 | 157,738 | 162,048 |
AMDOCS LIMITED | ||||||
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP | ||||||
(in thousands) | ||||||
Three months ended | ||||||
March 31, 2015 | ||||||
Reconciliation items | ||||||
GAAP |
Amortization of purchased intangible assets and other |
Equity based compensation expense |
Changes in fair value of certain acquisition- related liabilities |
Tax effect |
Non-GAAP |
|
Operating expenses: | ||||||
Cost of revenue | $580,571 | $ - | $(3,737) | $8,350 | $ - | $585,184 |
Research and development | 62,805 | - | (817) | - | - | 61,988 |
Selling, general and administrative | 107,186 | - | (5,271) | - | - | 101,915 |
Amortization of purchased intangible assets and other | 14,016 | (14,016) | - | - | - | - |
Total operating expenses | 764,578 | (14,016) | (9,825) | 8,350 | - | 749,087 |
Operating income | 138,000 | 14,016 | 9,825 | (8,350) | - | 153,491 |
Interest and other expense, net | 1,669 | - | - | - | - | 1,669 |
Income taxes | 20,070 | - | - | - | 3,105 | 23,175 |
Net income | $116,261 | $14,016 | $9,825 | $(8,350) | $(3,105) | $128,647 |
Three months ended | |||||
March 31, 2014 | |||||
Reconciliation items | |||||
GAAP |
Amortization of purchased intangible assets and other |
Equity based compensation expense |
Tax effect |
Non-GAAP |
|
Operating expenses: | |||||
Cost of revenue | $583,284 | $ - | $(4,369) | $ - | $578,915 |
Research and development | 63,104 | - | (872) | - | 62,232 |
Selling, general and administrative | 110,438 | - | (5,294) | - | 105,144 |
Amortization of purchased intangible assets and other | 16,180 | (16,180) | - | - | - |
Total operating expenses | 773,006 | (16,180) | (10,535) | - | 746,291 |
Operating income | 123,848 | 16,180 | 10,535 | - | 150,563 |
Income taxes | 11,583 | - | - | 5,222 | 16,805 |
Net income | $110,357 | $16,180 | $10,535 | $(5,222) | $131,850 |
AMDOCS LIMITED | ||||||
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP | ||||||
(in thousands) | ||||||
Six months ended | ||||||
March 31, 2015 | ||||||
Reconciliation items | ||||||
GAAP |
Amortization of purchased intangible assets and other |
Equity based compensation expense |
Changes in fair value of certain acquisition- related liabilities |
Tax effect |
Non-GAAP |
|
Operating expenses: | ||||||
Cost of revenue | $1,154,017 | $ - | $(7,981) | $24,906 | $ - | $1,170,942 |
Research and development | 126,446 | - | (1,754) | - | - | 124,692 |
Selling, general and administrative | 220,766 | - | (13,988) | - | - | 206,778 |
Amortization of purchased intangible assets and other | 28,115 | (28,115) | - | - | - | - |
Total operating expenses | 1,529,344 | (28,115) | (23,723) | 24,906 | - | 1,502,412 |
Operating income | 279,521 | 28,115 | 23,723 | (24,906) | - | 306,453 |
Interest and other expense, net | 125 | - | - | 3,921 | - | 4,046 |
Income taxes | 32,145 | - | - | - | 2,130 | 34,275 |
Net income | $247,251 | $28,115 | $23,723 | $(28,827) | $(2,130) | $268,132 |
Six months ended | |||||
March 31, 2014 | |||||
Reconciliation items | |||||
GAAP |
Amortization of purchased intangible assets and other |
Equity based compensation expense |
Tax effect |
Non-GAAP |
|
Operating expenses: | |||||
Cost of revenue | $1,140,687 | $ - | $(8,923) | $ - | $1,131,764 |
Research and development | 125,429 | - | (1,805) | - | 123,624 |
Selling, general and administrative | 222,397 | - | (12,772) | - | 209,625 |
Amortization of purchased intangible assets and other | 27,848 | (27,848) | - | - | - |
Total operating expenses | 1,516,361 | (27,848) | (23,500) | - | 1,465,013 |
Operating income | 244,538 | 27,848 | 23,500 | - | 295,886 |
Income taxes | 29,434 | - | - | 8,726 | 38,160 |
Net income | $211,792 | $27,848 | $23,500 | $(8,726) | $254,414 |
AMDOCS LIMITED | ||
Condensed Consolidated Balance Sheets | ||
(in thousands) | ||
As of | ||
March 31, 2015 | September 30, 2014 | |
ASSETS | ||
Current assets | ||
Cash, cash equivalents and short-term interest-bearing investments | $1,292,489 | $1,424,465 |
Accounts receivable, net, including unbilled of $103,752 and $134,523, respectively | 732,803 | 715,837 |
Deferred income taxes and taxes receivable | 165,031 | 148,346 |
Prepaid expenses and other current assets | 134,865 | 135,326 |
Total current assets | 2,325,188 | 2,423,974 |
Equipment and leasehold improvements, net | 285,402 | 288,956 |
Goodwill and other intangible assets, net | 2,085,788 | 2,106,452 |
Other noncurrent assets | 347,517 | 365,895 |
Total assets | $5,043,895 | $5,185,277 |
LIABILITIES AND SHAREHOLDERS' EQUITY | ||
Current liabilities | ||
Accounts payable, accruals and other | $800,848 | $785,548 |
Short-term financing arrangements | - | 210,000 |
Deferred revenue | 185,234 | 156,743 |
Deferred income taxes and taxes payable | 63,633 | 48,456 |
Total current liabilities | 1,049,715 | 1,200,747 |
Other noncurrent liabilities | 540,856 | 588,694 |
Shareholders' equity | 3,453,324 | 3,395,836 |
Total liabilities and shareholders' equity | $5,043,895 | $5,185,277 |
AMDOCS LIMITED | ||
Consolidated Statements of Cash Flows | ||
(in thousands) | ||
Six months ended March 31, | ||
2015 | 2014 | |
Cash Flow from Operating Activities: | ||
Net income | $247,251 | $211,792 |
Reconciliation of net income to net cash provided by operating activities: | ||
Depreciation and amortization | 83,303 | 76,739 |
Equity-based compensation expense | 23,723 | 23,500 |
Deferred income taxes | (27,260) | 9,690 |
Excess tax benefit from equity-based compensation | (3,628) | (438) |
Loss from short-term interest-bearing investments | 283 | 679 |
Net changes in operating assets and liabilities, net of amounts acquired: | ||
Accounts receivable | (14,623) | (30,503) |
Prepaid expenses and other current assets | 3,522 | (6,424) |
Other noncurrent assets | 14,898 | (14,867) |
Accounts payable, accrued expenses and accrued personnel | 8,428 | 36,041 |
Deferred revenue | 18,762 | 17,529 |
Income taxes payable | 18,363 | (16,273) |
Other noncurrent liabilities | (29,388) | 10,088 |
Net cash provided by operating activities | 343,634 | 317,553 |
Cash Flow from Investing Activities: | ||
Payments for purchase of equipment and leasehold improvements, net | (59,334) | (51,971) |
Proceeds from sale of short-term interest-bearing investments | 123,073 | 178,462 |
Purchase of short-term interest-bearing investments | (121,585) | (189,691) |
Net cash paid for acquisitions | (8,099) | (173,643) |
Other | 509 | 3,151 |
Net cash used in investing activities | (65,436) | (233,692) |
Cash Flow from Financing Activities: | ||
Payments under financing arrangements | (210,000) | (200,000) |
Repurchase of shares | (212,195) | (168,933) |
Proceeds from employee stock options exercised | 58,116 | 98,327 |
Payments of dividends | (48,377) | (41,564) |
Excess tax benefit from equity-based compensation | 3,628 | 438 |
Other | (5) | (281) |
Net cash used in financing activities | (408,833) | (312,013) |
Net decrease in cash and cash equivalents | (130,635) | (228,152) |
Cash and cash equivalents at beginning of period | 1,103,269 | 1,014,192 |
Cash and cash equivalents at end of period | $972,634 | $786,040 |
AMDOCS LIMITED | |||||
Supplementary Information | |||||
(in millions) | |||||
Three months ended | |||||
March 31, | December 31, | September 30, | June 30, | March 31, | |
2015 | 2014 | 2014 | 2014 | 2014 | |
North America | $ 646.7 | $ 659.1 | $ 662.7 | $ 647.2 | $ 651.7 |
Europe | 97.6 | 106.9 | 105.3 | 114.6 | 113.8 |
Rest of the World | 158.3 | 140.3 | 132.3 | 140.7 | 131.4 |
Total Revenue | $ 902.6 | $ 906.3 | $ 900.3 | $ 902.5 | $ 896.9 |
As of | |||||
March 31, | December 31, | September 30, | June 30, | March 31, | |
2015 | 2014 | 2014 | 2014 | 2014 | |
Managed Services Revenue | $ 448.8 | $ 467.1 | $ 436.4 | $ 438.0 | $ 426.3 |
Three months ended | |||||
March 31, | December 31, | September 30, | June 30, | March 31, | |
2015 | 2014 | 2014 | 2014 | 2014 | |
Customer Experience Systems | $ 877.1 | $ 882.4 | $ 871.5 | $ 870.8 | $ 863.6 |
Directory | 25.5 | 23.9 | 28.8 | 31.7 | 33.3 |
Total Revenue | $ 902.6 | $ 906.3 | $ 900.3 | $ 902.5 | $ 896.9 |
As of | |||||
March 31, | December 31, | September 30, | June 30, | March 31, | |
2015 | 2014 | 2014 | 2014 | 2014 | |
12-Month Backlog | $ 3,000 | $ 3,030 | $ 3,000 | $ 2,970 | $ 2,940 |
CONTACT:Matthew Smith Head of Investor RelationsAmdocs 314-212-8328 E-mail: dox_info@amdocs.com